HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Beguinot Selected Research

F Beguinot Research Topics

Disease

10Insulin Resistance
10/2020 - 04/2000
2Obesity
10/2020 - 07/2011
2Neoplasms (Cancer)
10/2012 - 02/2001
2Type 2 Diabetes Mellitus (MODY)
07/2011 - 12/2009
2Choriocarcinoma
06/2003 - 04/2003
1Inflammation (Inflammations)
10/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014
1Pathologic Processes
01/2014
1Breast Neoplasms (Breast Cancer)
10/2012
1Hyperandrogenism
07/2010
1Body Weight (Weight, Body)
07/2010
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
07/2010
1Leiomyoma (Uterine Fibroids)
01/2004
1Hyperglycemia
06/2003
1Glioma (Gliomas)
02/2001
1Essential Hypertension
04/2000

Drug/Important Bio-Agent (IBA)

8Insulin (Novolin)FDA Link
10/2012 - 04/2000
7Glucose (Dextrose)FDA LinkGeneric
01/2016 - 04/2003
3PhosphoproteinsIBA
07/2010 - 12/2006
2Phosphotransferases (Kinase)IBA
01/2004 - 04/2003
1LipidsIBA
10/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2014
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2014
1Conditioned Culture MediaIBA
10/2012
1Fatty Acids (Saturated Fatty Acids)IBA
10/2012
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2012
1Advanced Glycation End ProductsIBA
11/2011
1Leucine-Rich Repeat ProteinsIBA
07/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2011
1Testosterone (Sustanon)FDA Link
07/2010
1AndrogensIBA
07/2010
1Metformin (Glucophage)FDA LinkGeneric
07/2010
1Proteins (Proteins, Gene)FDA Link
07/2010
1Glucosamine (Dona)IBA
05/2010
1ets-Domain Protein Elk-1IBA
01/2004
1Leuprolide (Lupron)FDA LinkGeneric
01/2004
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2004
1Insulin Receptor Substrate ProteinsIBA
06/2003
1Vanadates (Orthovanadate)IBA
06/2003
1LeptinIBA
04/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2001
1Member 10c Tumor Necrosis Factor ReceptorsIBA
02/2001
1LigandsIBA
02/2001
1Antisense OligonucleotidesIBA
09/2000
1DNA (Deoxyribonucleic Acid)IBA
09/2000

Therapy/Procedure

3Therapeutics
10/2020 - 02/2001
1Aftercare (After-Treatment)
07/2010